Blog

Completing a UK/US merger can be a complicated and demanding undertaking at the best of times, let alone during a global pandemic. However, for UKI2S portfolio company Perfectus Biomed, and US-based Extherid Biosciences, this unique situation brought unforeseen advantages. We spoke to Sam Westgate, CEO, Perfectus Biomed, and Marnie Peterson, CEO, Extherid Biosciences, to learn […]

read more

Many companies set their sights on the large and lucrative US market, and those developing products based on synthetic biology are no exception. However, this isn’t as straightforward as it sounds. According to a report published by the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars, the path to approval for these […]

read more

I think I’ve reached the age that I can now begin a blog by saying ‘when I was a lad’…. Not so long ago the third world was widely viewed as an immensely impoverished  place, full of people who could barely read, and starvation was a major issue. When I was born in the mid […]

read more

1 2